Neurocrine Biosciences Inc.
NBIX | NASDAQ
$147.35
+$1.25 (+0.86%)
Nov 2, 2026, 9:49 AM ET · Market open
Market Data
Market Cap $14.98B
Enterprise Value $14.86B
Beta 0.40
Average Volume 1.26M
Shares Outstanding (Diluted) 104.2M
Shares Change YoY 3.17%
Institutional Ownership N/A
Exchange NASDAQ
ISIN US64125C1099
Price Performance
Price Change 1M 2.9%
Price Change 3M -11.4%
Price Change 6M 9.9%
Price Change YTD 3.9%
Price Change 1Y 3.8%
Price Change 3Y 31.1%
Price Change 5Y 57.7%
1M CAGR (ann.) -0.1%
1Y CAGR (ann.) 5.8%
5Y CAGR (ann.) 7.1%
All-Time CAGR 12.6%
Valuation
PE Ratio 21.42
Forward PE 11.83
PEG Ratio 0.20
Forward PEG 0.50
PS Ratio 4.40
Forward PS 3.30
PB Ratio 4.02
P/FCF Ratio 17.06
P/Adj. FCF Ratio 23.35
P/OCF Ratio 16.43
EV/Sales 4.41
EV/EBIT 17.07
EV/EBITDA 16.19
EV/FCF 17.08
Earnings Yield 4.7%
FCF Yield 5.9%
Adj. FCF Yield 4.3%
Financial Health
Net Cash $389.8M
Total Debt $401.8M
Cash & Short-Term Investments $389.8M
Total Assets $5.36B
Current Ratio 1.87
Quick Ratio 1.75
Debt / Equity Ratio 0.11
Debt / EBITDA 0.44
Debt / FCF 0.46
OCF / Debt 2.24
Interest Coverage 272.03
Altman Z-Score 6.88
Piotroski F-Score 4
Margins & Profitability
Gross Profit Margin 98.0%
Operating Profit Margin 23.4%
EBITDA Margin 27.2%
Net Profit Margin 20.9%
FCF Margin 25.8%
Adj. FCF Margin 18.9%
SBC / Revenue 7.0%
SBC Impact (per share) -26.9%
Returns
Return on Assets 13.2%
Return on Equity 21.1%
Return on Invested Capital 13.2%
Return on Capital Employed 17.6%
Return on Tangible Assets 26.8%
Historical Growth (CAGR)
Revenue CAGR 3Y 26.3%
Revenue CAGR 5Y 26.7%
Revenue CAGR 10Y 71.9%
EPS CAGR 3Y 58.0%
EPS CAGR 5Y 12.9%
EPS CAGR 10Y 41.0%
FCF CAGR 3Y 45.8%
FCF CAGR 5Y 28.8%
FCF CAGR 10Y 33.5%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 19
EPS Growth Next 3Y 21.8%
Revenue Growth Next 3Y 15.8%
Earnings Date Nov 2, 2026
EPS Estimate (next Q) $1.91
EPS Growth Est (next Q) -6.4%
Revenue Est (next Q) $1.04B
Revenue Growth Est (next Q) 31.3%
Fair Value Estimates
Graham Number $74.91
Graham Upside -48.7%
Lynch Fair Value $87.91
Lynch Upside -39.8%
Price Target $204.18
Price Target Upside 39.8%
Cash Flow
Operating Cash Flow $898.1M
Free Cash Flow $870.4M
Adj. Free Cash Flow $635.9M
FCF Per Share $8.62
OCF Per Share $8.89
OCF/S Ratio 26.6%
Income Statement
Revenue $3.37B
Gross Profit $3.31B
Operating Income $788.9M
EBITDA $918.1M
Net Income $705.5M
EPS (Diluted) $6.82
Revenue / Employee $1.35M
Profit / Employee $282.2K
Employees 2,500
Add to Watchlist
Select watchlists to add or remove NBIX